Skip to content

Biobank for blood samples and biomaterials samples of patients with spinal diseases

Biobank for blood samples and biomaterials samples of patients with spinal diseases - biobank spinal diseases

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00037561
Enrollment
2000
Registered
2025-11-07
Start date
2025-12-01
Completion date
Unknown
Last updated
2025-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Degeneration of the spine (e.g., herniated disc, spinal canal stenosis, spondylolisthesis), vertebral infection (e.g., spondylitis, spondylodiscitis, facet joint arthritis), and osteoporotic vertebral/pelvic fracture.

Interventions

Group 1: Patients with (suspected) underlying degeneration of the spine (e.g., herniated disc, spinal canal stenosis, spondylolisthesis), vertebral infection (e.g., spondylitis, spondylodiscitis, face

Sponsors

Universitätsklinikum Bonn
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 100 Years

Inclusion criteria

Inclusion criteria: • Suspicion of a degenerative, inflammatory disease or osteoporotic fracture of the spine or pelvic skeleton • The patient is able to understand the nature, significance, and implications of the decision to participate in the study and to act in accordance with their wishes. • A declaration of consent dated and signed by the patient is available.

Exclusion criteria

Exclusion criteria: Lack of consent to participate in the study

Design outcomes

Primary

MeasureTime frame
Difficult to specify when collecting biomaterials. With the consent of the patients and the ethics committee, the materials are to be stored for 20 years for various different investigations. Duration for individual patients: From inclusion in the study/admission to routine discharge from inpatient treatment, clinical follow-up examination during routine check-ups if necessary. This involves the collection of blood samples and intraoperative samples and the recording of clinical findings, e.g., using the Oswestry Disability Index.

Secondary

MeasureTime frame
The aim is to build up a collection of tissue samples (intraoperative biomaterial, e.g. from intervertebral discs) and corresponding blood samples over a period of 10-20 years and to investigate various microbiological and immunological questions using different methods.

Countries

Germany

Contacts

Public ContactLioba Bürvenich

Universitätsklinikum Bonn Klinik und Poliklinik für Orthopädie und Unfallchirurgie

lioba.buervenich@ukbonn.de+4915118853299

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026